Larimar Therapeutics Ownership | Who Owns Larimar Therapeutics?
Larimar Therapeutics Ownership Summary
Larimar Therapeutics is owned by 48.74% institutional investors, 1.43% insiders, and 49.83% retail investors. Deerfield management company, l.p. (series c) is the largest institutional shareholder, holding 33.19% of LRMR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.10% of its assets in Larimar Therapeutics shares.
LRMR Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Larimar Therapeutics | 48.74% | 1.43% | 49.83% |
Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Deerfield management company, l.p. (series c) | 21.23M | 33.19% | $45.65M |
Janus henderson group | 6.44M | 10.10% | $24.94M |
Ra capital management | 6.05M | 9.45% | $13.00M |
Blue owl capital lp | 4.65M | 7.29% | $18.01M |
Goldman sachs group | 4.15M | 6.51% | $16.07M |
Blackrock | 3.13M | 5.85% | $22.72M |
Blackrock funding, inc. /de | 3.27M | 5.12% | $12.64M |
Vanguard group | 2.19M | 3.44% | $8.49M |
Opaleye management | 1.91M | 2.99% | $4.12M |
State street | 916.20K | 1.71% | $6.64M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Blue owl capital lp | 4.65M | 4.15% | $18.01M |
Opaleye management | 1.91M | 0.92% | $4.12M |
Deerfield management company, l.p. (series c) | 21.23M | 0.90% | $45.65M |
Altium capital management lp | 505.00K | 0.55% | $1.95M |
Mangrove partners | 770.23K | 0.33% | $2.98M |
Sphera funds management | 455.60K | 0.32% | $1.76M |
Dafna capital management | 371.43K | 0.23% | $798.58K |
Ra capital management | 6.05M | 0.22% | $13.00M |
Velan capital investment management lp | 28.00K | 0.06% | $60.20K |
Ubs oconnor | 188.54K | 0.06% | $729.66K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Opaleye management | 1.91M | 0.92% | 1.91M |
Janus henderson group | 6.44M | 0.01% | 876.43K |
Blackrock | 3.13M | 0.00% | 795.19K |
Blue owl capital lp | 4.65M | 4.15% | 486.21K |
Millennium management | 673.01K | 0.00% | 418.06K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Adage capital partners gp | - | - | -2.10M |
Driehaus capital management | 356.00K | 0.01% | -913.86K |
Fred alger management | - | - | -737.55K |
Stempoint capital lp | - | - | -704.35K |
Logos global management lp | - | - | -700.00K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Opaleye management | 1.91M | 0.92% | 1.91M | $4.12M |
Alps advisors | 51.59K | 0.00% | 51.59K | $199.65K |
Walleye trading | 25.00K | 0.00% | 25.00K | $96.75K |
Proshare advisors | 14.87K | 0.00% | 14.87K | $57.55K |
China universal asset management | 13.53K | 0.00% | 13.53K | $52.36K |
Sold Out
Holder | Change |
---|---|
National bank of canada /fi/ | -2.00 |
Federated hermes | -3.00 |
Ifp advisors | -4.00 |
Nelson, van denburg & campbell wealth management group | -5.00 |
Signaturefd | -8.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 10 | -91.80% | 31,178,885 | -50.84% | 48 | 0.49% | 5 | -92.19% | 1 | -97.14% |
Dec 31, 2024 | 116 | -8.66% | 61,296,513 | -4.71% | 96 | 0.95% | 61 | -6.15% | 32 | -5.88% |
Sep 30, 2024 | 127 | 15.45% | 64,329,114 | -1.50% | 100 | 0.68% | 65 | 4.84% | 34 | - |
Jun 30, 2024 | 110 | -1.79% | 65,308,472 | 2.69% | 121 | 0.58% | 62 | -17.33% | 34 | 54.55% |
Mar 31, 2024 | 112 | 51.35% | 63,594,673 | 61.18% | 144 | 1.79% | 75 | 150.00% | 22 | -15.38% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard US Total Market Shares ETF | 1.34M | 2.10% | - |
Vanguard Total Stock Mkt Idx Inv | 1.31M | 2.04% | - |
iShares Russell 2000 ETF | 1.08M | 1.68% | 528.00 |
Fidelity Advisor Biotechnology I | 524.80K | 0.82% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 510.24K | 0.80% | - |
Invesco Dorsey Wright SmallCap Momt ETF | 422.53K | 0.66% | - |
Fidelity Small Cap Index | 422.46K | 0.66% | - |
Alger Small Cap Growth B | 398.96K | 0.62% | - |
iShares Russell 2000 Growth ETF | 390.40K | 0.61% | - |
Heptagon Driehaus US Micro Cap Eq C$ Acc | 387.15K | 0.61% | -2.69K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 16, 2024 | Hamilton Thomas Edward | - | Buy | $500.00K |
Feb 16, 2024 | Flynn James E | * Director by Deputization | Buy | $12.50M |
Feb 16, 2024 | Flynn James E | * Director by Deputization | Buy | $12.50M |
Feb 16, 2024 | Flynn James E | * Director by Deputization | Buy | $12.50M |
Feb 14, 2024 | THOMAS FRANK E | - | Buy | $22.00K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | - |
2025 Q1 | - | - |
2024 Q2 | - | - |
2024 Q1 | 5 | - |
2023 Q4 | 1 | - |
LRMR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools